Safe Life Corp. is utilizing 21st century technology on today’s microbial challenges. Safe Life’s applied research into the development of stable, broad-spectrum, fast acting antimicrobial technologies has resulted in the creation of multiple “next generation” products for the protection of life and property from microbial threats. Products and services already in the field, on government contract or nearing commercialization include protective apparel and equipment; means of reducing healthcare-associated infections (HAI); advances in wound care management; air, fluid and blood filtration; dermatological products and even paints. Safe Life also provides practical and in-depth scientific education to the public, businesses and healthcare sectors, addressing preparedness for pandemic eventualities, bioterrorist attacks, and the prevention of healthcare-associated infections.

Backed by funding from VantagePoint Venture Partners and other investors, Safe Life Corp. is well positioned to become a leader in the sector. Triosyn Research Laboratories forms the technical heart of the corporation’s microbiological, chemical, engineering and cutting-edge testing capabilities. The company aims to leverage its proprietary technology through collaborative partnerships in the development of antimicrobial product applications worldwide.

Safe Life Corp. and Triosyn®
In 2006, Safe Life Corp. merged talent with Triosyn Corp., developers of the patented Triosyn® resin, an antimicrobial agent capable of rapidly inactivating a broad range of fungal, bacterial, viral and protozoan microorganisms.

Safe Life Corp. is headquartered in San Diego, California with state-of-the-art research and development facilities in Montreal, Canada and operations and engineering in Williston, Vermont, and Ipoh, Malaysia.

Safe Life. Because life's biggest threats are microscopic.